Download PDF
1 / Pages

Other users also viewed these articles

Glycaemic control during the COVID-19 pandemic: A catastrophe or a sign of hope for the person with type 1 Diabetes Mellitus? Diogo Ramalho; Ana Rouxinol-Dias; Patrícia Tavares; Sara Correia; Lúcia Almeida; Helena Alves; Gustavo Rocha; Maria João Oliveira;
Endocrinol Diabetes Nutr. 2022;69:476-82
Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19 Francisco Javier Carrasco-Sánchez; Enrique Carretero-Anibarro; Manuel Ángel Gargallo; Ricardo Gómez-Huelgas; Juan Francisco Merino-Torres; Domingo Orozco-Beltrán; Pedro José Pines Corrales; Manuel Antonio Ruiz Quintero;
Endocrinol Diabetes Nutr. 2022;69:209-18
Clinical characteristics and management of type 1 diabetes in Spain. The SED1 study Fernando Gómez-Peralta; Edelmiro Menéndez; Santiago Conde; Ignacio Conget; Anna Novials;
Endocrinol Diabetes Nutr. 2021;68:642-53